Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • US shares mostly pull back, XJO to open lower
    • Market Update

    US shares mostly pull back, XJO to open lower

    The XJO is expected to fall on open this morning following a strong pullback in the U.S overnight. Their futures have moved into the green. Yesterday we rallied from the small breather we had the prior session and managed to hold most of the gains into the close. Our highs were roughly 8,100, and with

    Read More
    Public
  • Global Health achieves positive cashflow within 18 months of Mathew Cherian’s return
    • News

    Global Health achieves positive cashflow within 18 months of Mathew Cherian’s return

    Digital health solutions company Global Health (ASX: GLH) has achieved a major milestone for shareholders, inflecting into positive operating cashflow for the first time and just 18 months after major shareholder Mathew Cherian took over leadership of the company as Managing Director.  For the quarter ended 30 June 2024, Global Health reported $3.0 million in

    Read More
    Public
  • A match made in wellness – NGS partners with The Healthy Chef for North American expansion
    • News

    A match made in wellness – NGS partners with The Healthy Chef for North American expansion

    In an over stimulating world, where infinite options can indeed be overwhelming, making an informed decision especially when it comes to our health; can be mentally draining. In this respect, companies like Nutritional Growth Solutions (ASX: NGS), are trying to shape the future of clean eating with their products and collaborations. Recently, NGS, a U.S

    Read More
    Public
  • Fresh highs again after strong US earnings
    • Market Update

    Fresh highs again after strong US earnings

    The XJO is expected to open higher this morning following a renewed rally in the U.S overnight. Their futures have moved into the green. The rally in the U.S was largely across the board rather than be limited to just tech and tech adjacent sectors – and so our market will feel comfortable pricing in

    Read More
    Public
  • CleanSpace sees sustainable growth with pivot to industrial sectors after the pandemic boom
    • News

    CleanSpace sees sustainable growth with pivot to industrial sectors after the pandemic boom

    While many pandemic emergent companies grapple with cautious consumerism and stale demand, CleanSpace (ASX: CSX), a respiratory technology company, breathes a sigh of relief with their 30% sales growth as compared to last year.  In April 2024, they launched CleanSpace WORK, their lightest powered respirator, and at a lesser price point. Their new target audience

    Read More
    Public
  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted

    Medical diagnostics tech company Compumedics (ASX: CMP) has seen a surge in sales with its unaudited sales data showing $49 million in revenue for FY24 which would be a new record for the Company.  Sales were driven by Compumedics’ Australian sleep and neurodiagnostic businesses which experienced significant growth, bolstered by two major Magnetoencephalography (MEG) orders

    Read More
    Public
  • «
  • ‹
  • 53
  • 54
  • 55
  • 56
  • 57
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.